Oxidative modification, inflammation and amyloid in the normal and diabetic cat pancreas

Journal of Comparative Pathology

Volumn 151, Issue 4, 2014, Pages 352-362

  Herndon, A M ^a   Breshears, M A ^a   McFarlane, D ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Amyloid; Cat; Diabetes; Inflammation

Indexed keywords

4 HYDROXYNONENAL; AMYLIN; AMYLOID; INSULIN; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERGLYCEMIA; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; AMYLOID PLAQUE; ANIMAL; CAT DISEASE; FEMALE; MALE; METABOLISM; OXIDATIVE STRESS; PANCREAS ISLET; PATHOLOGY; PHYSIOLOGY; VETERINARY;

ANIMALS; CAT DISEASES; CATS; DIABETES MELLITUS, TYPE 2; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; MALE; OXIDATIVE STRESS; PANCREAS; PLAQUE, AMYLOID;

EID: 84923411019     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2014.06.004     Document Type: Article

References (34)

1. Acharya J.D., Ghaskadbi S.S. Islets and their antioxidant defense. Islets 2010, 2:225-235.
2. Bast A., Wolf G., Oberbaumer I., Walther R. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002, 45:867-876.
3. Boni-Schnetzler M., Ehses J.A., Faulenbac M., Donath M.Y. Insulitis in type 2 diabetes. Diabetes, Obesity and Metabolism 2008, 10(Suppl. 4):201-204.
4. Boyle J., Thompson T., Gregg E., Barker L., Williamson D. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Health Metrics 2010, 8:29.
5. Brender J.R., Hartman K., Nanga R.P., Popovych N., de la Salud Bea R., et al. Role of zinc in human islet amyloid polypeptide aggregation. Journal of the American Chemical Society 2010, 132:8973-8983.
6. Donath M.Y., Ehses J.A., Maedler K., Schumann D.M., Ellingsgaard H., et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005, 54(Suppl. 2):S108-S113.
7. Gasa R., Gomis R., Casamitjana R., Novials A. High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas 2001, 22:307-310.
8. Höppener J., Nieuwenhuis M., Vroom T., Ahrén B., Lips C. Role of islet amyloid in type 2 diabetes mellitus: consequence or cause?. Molecular and Cellular Endocrinology 2002, 197:205-212.
9. Hui H., Wright C., Perfetti R. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 2001, 50:785-796.
10. Ihara Y., Toyokuni S., Uchida K., Odaka H., Tanaka T., et al. Hyperglycemia causes oxidative stress in pancreatic beta-cells of gk rats, a model of type 2 diabetes. Diabetes 1999, 48:927-932.
11. Jaikaran E.T., Clark A. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochimica et Biophysica Acta 2001, 1537:179-203.
12. Johnson K.H., O'Brien T.D., Jordan K., Westermark P. Impaired glucose tolerance is associated with increased islet amyloid polypeptide (IAPP) immunoreactivity in pancreatic beta cells. American Journal of Pathology 1989, 135:245-250.
13. Larsen C.M., Faulenbach M., Vaag A., Ehses J.A., Donath M.Y., et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009, 32:1663-1668.
14. Li N., Brun T., Cnop M., Cunha D.A., Eizirik D.L., et al. Transient oxidative stress damages mitochondrial machinery inducing persistent beta-cell dysfunction. Journal of Biological Chemistry 2009, 284:23602-23612.
15. Lutz T., Rand J. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats. Canadian Veterinary Journal 1996, 37:27-34.
16. Lutz T.A., Ainscow J., Rand J.S. Frequency of pancreatic amyloid deposition in cats from south-eastern Queensland. Australian Veterinary Journal 1994, 71:254-256.
17. Lutz T.A., Rand J.S. Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques. Journal of Comparative Pathology 1997, 116:157-170.
18. Ma Z., Westermark G.T., Johnson K.H., O'Brien T.D., Westermark P. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats. Amyloid 1998, 5:255-261.
19. Meier J.J., Kayed R., Lin C.Y., Gurlo T., Haataja L., et al. Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. American Journal of Physiology, Endocrinology and Metabolism 2006, 291:E1317-E1324.
20. Modak M.A., Parab P.B., Ghaskadbi S.S. Control of hyperglycemia significantly improves oxidative stress profile of pancreatic islets. Islets 2011, 3:234-240.
21. Mulder H., Ahren B., Sundler F. Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents. Molecular and Cellular Endocrinology 1995, 114:101-109.
22. Mulder H., Ahren B., Sundler F. Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats. Diabetologia 1996, 39:649-657.
23. O'Brien T. Pathogenesis of feline diabetes mellitus. Molecular and Cellular Endocrinology 2002, 197:213-219.
24. O'Brien T.D., Butler P.C., Westermark P., Johnson K.H. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. Veterinary Pathology 1993, 30:317-332.
25. O'Brien T.D., Hayden D.W., Johnson K.H., Fletcher T.F. Immunohistochemical morphometry of pancreatic endocrine cells in diabetic, normoglycaemic glucose-intolerant and normal cats. Journal of Comparative Pathology 1986, 96:357-369.
26. Pieber T.R., Stein D.T., Ogawa A., Alam T., Ohneda M., et al. Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. American Journal of Physiology 1993, 265:E446-E453.
27. Prahl A., Guptill L., Glickman N.W., Tetrick M., Glickman L.T. Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. Journal of Feline Medicine and Surgery 2007, 9:351-358.
28. Rieder J., Seipel J., Biermann K., Nolte I. Canine and feline diabetes mellitus: a retrospective epidemiological study (1996-2006). Tierarztliche Praxis; Ausgabe K, Kleintiere/Heimtiere 2008, 36:169-175.
29. Robertson R.P., Harmon J., Tran P.O., Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004, 53(Suppl. 1):S119-S124.
30. Weise K., Radovan D., Gohlke A., Opitz N., Winter R. Interaction of HIAPP with model raft membranes and pancreatic beta-cells: cytotoxicity of HIAPP oligomers. Chembiochem 2010, 11:1280-1290.
31. Westermark P., Andersson A., Westermark G.T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiology Reviews 2011, 91:795-826.
32. Westermark P., Engstrom U., Johnson K.H., Westermark G.T., Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proceedings of the National Academy of Sciences USA 1990, 87:5036-5040.
33. Xu X., D'Hoker J., Stange G., Bonne S., De Leu N., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132:197-207.
34. Zhao H.L., Sui Y., Guan J., He L., Gu X.M., et al. Amyloid oligomers in diabetic and nondiabetic human pancreas. Translational Research 2009, 153:24-32.